Quick Takeaways
- Kemal Malik has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $100,235.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Kemal Malik
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Kemal Malik is at least $100,235 dollars as of 06 Jan 2026. Kemal Malik is the Director of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $100.2K.
- Signature
- /s/ Matthew Bartholomae, Attorney-in-fact for Kemal Malik
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kemal Malik and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Cartesian Therapeutics, Inc. ($100,235).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Kemal Malik
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Director | $100,235 | 02 Jan 2026 | ||
| XLRN | ACCELERON PHARMA INC | Director | 19 Nov 2021 |
Insider Transactions Reported by Kemal Malik:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.